Results 71 to 80 of about 20,494 (217)
An Atypical Case of Pityriasis Rosea Gigantea after Influenza Vaccination
Case Reports in Dermatology, 2014 Pityriasis rosea is a common erythematosquamous eruption, typically presenting along the cleavage lines of the skin. A wide spectrum of atypical manifestations may challenge even the most experienced physician.
Dimitrios Papakostas +5 more
doaj +1 more source
Skin manifestations following anti-COVID-19 vaccination: A multicentricstudy from Turkey [PDF]
, 2023 Purpose: After the emergence of the pandemic caused by the COVID-19 virus, vaccination with various vaccines has started to be implemented across the world.
Demirseren, Düriye Deniz +15 more
core +1 more source
Особенности клиники и течения розового лишая [PDF]
, 2012 кожные болезнилишай ...
Адаскевич, В. П. +1 more
core +1 more source
Pityriasis Rosea in a Female Runner [PDF]
, 2023 CASE HISTORY: The patient was a 40-year-old, physically active, mother and teacher. She had no previous history of autoimmune disease, Shingles, or other skin disorder. She reported having Herpes Zoster (Chicken Pox) at about six years old. In this case,
Long, Melissa D.
core +1 more source
Recurrent pityriasis rosea: A case report
Human Vaccines & Immunotherapeutics, 2018 Pityriasis rosea is a papulosquamous skin disorder that occurs most commonly between the ages of 10 and 35 years. Recurrent pityriasis rosea is rare. We report a patient suffering from recurrent pityriasis rosea, whose etiology may be related to either ...
Ang Li, Ping Li, Yanqiong Li, Wenfei Li
doaj +1 more source
Human herpesvirus‐6, ‐7, and Epstein‐Barr virus reactivation in pityriasis rosea during COVID‐19
Journal of Medical Virology, 2020 Cutaneous manifestations during Coronavirus Disease 2019 (COVID-19) include pityriasis rosea (PR) and PR-like eruptions1-3 . We describe a patient with PR demonstrating that concurrent viral reactivations may occur during COVID-19.
F. Drago +3 more
semanticscholar +1 more source
Molecular study of recent virus and its relationship to Pityriasis rosea.
Journal of population therapeutics and clinical pharmacology = Journal de la therapeutique des populations et de la pharmacologie clinique, 2022 BACKGROUND A new type of coronavirus family severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) that has been detected in individuals with several clinical symptoms named COVID-19, was recognized as a pandemic on March 11, 2020.
Ahmed Abdulhussein Kawen
semanticscholar +1 more source
International Journal of Dermatology, Volume 64, Issue 6, Page 1013-1020, June 2025.ABSTRACT Despite increasing attention regarding skin diseases in individuals with skin of color (SoC), there remains a significant gap in understanding and identifying inflammatory nail disorders in this population. This systematic review aims to synthesize the clinical and onychoscopic features of inflammatory nail disorders in patients with SoC ...
Lea Tordjman +3 more
wiley +1 more source
Ibuprofen-induced pityriasis rosea and fixed-drug eruption
Indian Journal of Paediatric DermatologyPityriasis rosea (PR) is a common acute and usually self-limiting papulosquamous dermatosis that typically affects children and young adults. Fixed-drug eruption (FDE) is a type of cutaneous adverse drug reaction that reoccurs at the same site when the ...
D. Behera +4 more
semanticscholar +1 more source
Cutaneous Manifestations of COVID‐19: A Descriptive Analysis of a Southeastern USA Purposive Sample
International Wound Journal, Volume 22, Issue 4, April 2025.ABSTRACT This study describes characteristics and factors associated with cutaneous manifestations of COVID‐19 encountered across acute inpatient, and critical care units in a large Southeastern USA public hospital from March 1, 2020, through November 01, 2021.
Shannon S. Layton +5 more
wiley +1 more source